(0.05%) 5 520.00 points
(0.10%) 39 885 points
(0.16%) 19 783 points
(-0.06%) $81.58
(0.60%) $2.83
(-0.27%) $2 338.10
(0.10%) $29.56
(0.46%) $1 006.40
(0.07%) $0.932
(-0.09%) $10.52
(0.00%) $0.788
(-0.85%) $87.25
-2.79% $ 34.89
Live Chart Being Loaded With Signals
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 1.20M |
Średni wolumen | 915 683 |
Kapitalizacja rynkowa | 1.91B |
EPS | $-0.560 ( Q1 | 2024-05-10 ) |
Następna data zysków | ( $-0.530 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-17.36 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.111 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-07 | Oliger Christy J. | Buy | 25 000 | Stock Option (right to buy) |
2024-06-07 | Oliger Christy J. | Sell | 0 | Class A Common Stock |
2024-05-16 | Young Joseph R | Buy | 18 151 | Class A Common Stock |
2024-05-16 | Young Joseph R | Sell | 20 651 | Stock Option (right to buy) |
2024-05-15 | Young Joseph R | Buy | 8 221 | Class A Common Stock |
INSIDER POWER |
---|
1.64 |
Last 99 transactions |
Buy: 3 013 345 | Sell: 2 216 434 |
Wolumen Korelacja
Vera Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
TIL | 0.931 |
FSEA | 0.904 |
HQY | 0.9 |
EWTX | 0.899 |
INBK | 0.898 |
YMAB | 0.895 |
APPF | 0.879 |
UCTT | 0.878 |
MSVB | 0.877 |
VRNT | 0.877 |
10 Najbardziej negatywne korelacje | |
---|---|
CSSEN | -0.969 |
SCPS | -0.937 |
WABC | -0.934 |
SGML | -0.927 |
SIFY | -0.927 |
CNSP | -0.927 |
AXDX | -0.927 |
CNTY | -0.925 |
VRM | -0.924 |
IRBT | -0.924 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vera Therapeutics, Inc. Korelacja - Waluta/Towar
Vera Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $1.86M (0.00 %) |
EPS: | $-2.25 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $1.86M (0.00 %) |
EPS: | $-2.25 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $846 000 (0.00 %) |
EPS: | $-3.35 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-8.00 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej